CN107201318B - Recombinant bacterium for producing cephalosporin C and application thereof - Google Patents

Recombinant bacterium for producing cephalosporin C and application thereof Download PDF

Info

Publication number
CN107201318B
CN107201318B CN201710623482.XA CN201710623482A CN107201318B CN 107201318 B CN107201318 B CN 107201318B CN 201710623482 A CN201710623482 A CN 201710623482A CN 107201318 B CN107201318 B CN 107201318B
Authority
CN
China
Prior art keywords
recombinant
cpc
strain
recombinant bacterium
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201710623482.XA
Other languages
Chinese (zh)
Other versions
CN107201318A (en
Inventor
刘钢
刘佳佳
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institute of Microbiology of CAS
Original Assignee
Institute of Microbiology of CAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institute of Microbiology of CAS filed Critical Institute of Microbiology of CAS
Priority to CN201710623482.XA priority Critical patent/CN107201318B/en
Publication of CN107201318A publication Critical patent/CN107201318A/en
Application granted granted Critical
Publication of CN107201318B publication Critical patent/CN107201318B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/1085Transferases (2.) transferring alkyl or aryl groups other than methyl groups (2.5)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P35/00Preparation of compounds having a 5-thia-1-azabicyclo [4.2.0] octane ring system, e.g. cephalosporin
    • C12P35/06Cephalosporin C; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y205/00Transferases transferring alkyl or aryl groups, other than methyl groups (2.5)
    • C12Y205/01Transferases transferring alkyl or aryl groups, other than methyl groups (2.5) transferring alkyl or aryl groups, other than methyl groups (2.5.1)
    • C12Y205/01006Methionine adenosyltransferase (2.5.1.6), i.e. adenosylmethionine synthetase

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The invention discloses a recombinant bacterium for producing cephalosporin C and application thereof. The preparation method of the recombinant bacterium comprises the following steps: introducing a substance for improving the expression and/or activity of adenosylmethionine synthetase into the fermentation strain to obtain the recombinant strain. Experiments prove that by adopting the recombinant bacterium to produce CPC, the addition of methionine in a culture medium is omitted, and the yield of CPC is improved. Compared with the original strain cephalosporium acremonium CGMCC3.3795, the recombinant strain has stronger CPC synthesis capacity. The recombinant bacterium provided by the invention has important application value in the aspects of improving the yield of CPC, reducing the production cost and the like.

Description

Recombinant bacterium for producing cephalosporin C and application thereof
Technical Field
The invention relates to the field of applied industrial microorganisms, in particular to a recombinant bacterium for producing cephalosporin C and application thereof.
Background
Cephalosporin C (CPC) is a main raw material for producing 7-aminocephalosporanic acid (7-ACA), an important intermediate of Cephalosporin antibiotics. Currently, CPC is obtained by fermentation mainly using Acremonium chrysogenum in industry. The biosynthesis pathway of CPC in Cephalosporium acremonium is basically and clearly researched, and the genetic operation system of Cephalosporium acremonium is relatively mature, so that a good foundation is laid for directionally transforming the important industrial fungus by utilizing a genetic engineering means.
Methionine can significantly stimulate the production of CPC in cephalosporium acremonium, has long been used as an accelerant for the production of CPC in cephalosporium acremonium, and has been used in industrial production. With the continuous increase of the fermentation level of CPC of Acremonium acremonium, methionine becomes an important factor influencing the production cost of CPC. Therefore, it would be of great value to obtain a strain that could still increase the fermentation level of CPC without adding methionine to the medium.
Disclosure of Invention
The technical problem to be solved by the invention is how to improve the fermentation level of CPC when methionine is not added into the culture medium.
In order to solve the technical problems, the invention firstly provides a recombinant bacterium.
The preparation method of the recombinant bacterium provided by the invention can be as follows: and improving the content and/or activity of adenosylmethionine synthetase in the fermentation strain to obtain the recombinant strain.
In the recombinant bacterium, the amino acid sequence of the adenosylmethionine synthetase is shown as a sequence 2 in a sequence table.
In the above recombinant bacterium, the method for increasing the content and/or activity of adenosylmethionine synthetase in the producing bacterium may be to introduce a nucleic acid molecule encoding adenosylmethionine synthetase into the producing bacterium.
In the recombinant bacterium, the step of introducing the nucleic acid molecule encoding the adenosylmethionine synthetase into the initial bacterium can be realized by introducing a recombinant vector into the initial bacterium; the recombinant vector may be a recombinant plasmid obtained by inserting a nucleic acid molecule encoding an adenosylmethionine synthetase into an expression vector.
In any of the recombinant bacteria, the outgrowth bacteria can be cephalosporium acremonium. The Acremonium acremonium can be specifically Acremonium CGMCC 3.3795.
The nucleic acid molecule encoding adenosylmethionine synthetase as described above can be specifically represented by sequence 1 in the sequence table.
Any of the above-described nucleic acid molecules encoding an adenosylmethionine synthetase also falls within the scope of the present invention.
Also within the scope of the present invention is an expression cassette, a recombinant vector or a recombinant microorganism comprising any of the above-described nucleic acid molecules encoding an adenosylmethionine synthetase.
The expression cassette can be expression cassette a; the expression cassette a comprises a promoter, a nucleic acid molecule encoding an adenosylmethionine synthetase and a terminator. The promoter may be a CaMV35S promoter, a NOS promoter or an OCS promoter. The terminator may be a NOS terminator or an OCS polyA terminator.
The nucleotide sequence of the expression cassette A can be shown as a sequence 4 in a sequence table. In the expression cassette a: the 1 st to 2093 th positions of the sequence 4 in the sequence table from the 5' end are promoters, the 2109 th to 3293 th positions are nucleic acid molecules for coding adenosylmethionine synthetase, and the 3319 th to 3838 th positions are terminators.
The recombinant vector may be a recombinant plasmid obtained by inserting a nucleic acid molecule encoding an adenosylmethionine synthetase into an expression vector. The expression vector may be plasmid pAg 1-G418-P-T. The recombinant vector can be specifically a recombinant plasmid pAg 1-AcsamsoE. The recombinant plasmid pAg1-AcsamsoE can be specifically a recombinant plasmid obtained by replacing a small fragment between restriction enzymes PacI and AscI of a plasmid pAg1-G418-P-T with a DNA molecule shown in a sequence 1 of a sequence table. The recombinant plasmid pAg1-Acsamso expresses adenosylmethionine synthetase shown in sequence 2 of the sequence table.
The recombinant microorganism can be obtained by introducing the recombinant vector into the starting microorganism.
The starting microorganism may be a yeast, bacterium, algae or fungus. The bacteria may be gram positive or gram negative bacteria. The gram-negative bacterium may be Agrobacterium tumefaciens (Agrobacterium tumefaciens). The Agrobacterium tumefaciens (Agrobacterium tumefaciens) may specifically be Agrobacterium tumefaciens AGL-1.
The recombinant microorganism can be AGL-1/pAg1-Acsamso OE specifically; AGL-1/pAg1-AcsamsoE is a recombinant Agrobacterium obtained by introducing the recombinant plasmid pAg1-AcsamsoE into Agrobacterium tumefaciens AGL-1.
In order to solve the technical problems, the invention also provides a microbial inoculum which contains any one of the recombinant bacteria.
The recombinant bacterium described above, or any nucleic acid molecule encoding an adenosylmethionine synthetase described above, or an expression cassette, a recombinant vector or a recombinant microorganism comprising a nucleic acid molecule encoding an adenosylmethionine synthetase described above, or the use of the microbial inoculum for producing cephalosporin C is also within the scope of the present invention.
In order to solve the technical problems, the invention also provides a method for producing cephalosporin C, which can comprise the step of carrying out fermentation culture on any one of the recombinant bacteria to obtain cephalosporin C.
In the above method, the fermentation medium used in the fermentation culture may be a methionine-free medium or a methionine-containing medium. The fermentation medium used in the fermentation culture can be specifically an original MDFA fermentation medium or a modified MDFA fermentation medium. The fermentation culture inoculum size is 5-15% (such as 5-10%, 10-15%, 5%, 15% or 10%). The culture condition of the fermentation culture is that the fermentation culture is carried out for 100 h-160 h (such as 100 h-120 h, 120 h-144 h, 144 h-160 h, 100h, 120h, 160h or 144h) at 25 ℃ -30 ℃ (such as 25 ℃ -28 ℃, 28 ℃ -30 ℃, 25 ℃, 30 ℃ or 28 ℃).
In the above method, the "fermenting and culturing the recombinant bacterium" may further include preparing a seed solution. The steps for preparing the seed liquid are as follows: and (5) culturing the recombinant strain in a shake flask to obtain a seed solution. The shake flask culture medium used for the shake flask culture may be a methionine-containing medium. The shake flask culture medium used for shake flask culture can be specifically the original MDFA fermentation medium. The shake flask culture medium used for shake flask culture can be specifically the modified MDFA fermentation medium. The initial biomass in the shake flask culture is 1X 107cfu/40mL~5×107cfu/40mL (e.g., 1X 10)7cfu/40mL~3×107cfu/40mL、3×107cfu/40mL~5×107cfu/40mL、1×107cfu/40mL、5×107cfu/40mL or 3X 107cfu/40 mL). The shake flask culture inoculum size is 5-15% (e.g. 5-10%, 10-15%, 5%, 15% or 10%). The culture conditions of the shake flask culture are 25-30 ℃ (such as 25-28 ℃, 28-30 ℃, 25 ℃, 30 ℃ or 28 ℃), 180 rpm-260 rpm (such as 180 rpm-220 rpm, 220 rpm-260 rpm, 180rpm, 260rpm or 220rpm), and 40 h-60 h (such as 40 h-48 h, 48 h-60 h, 40h, 60h or 48 h).
Any of the above methionine may be particularly DL-type methionine.
The preparation method of any one of the original MDFA fermentation culture media comprises the following steps: mixing sucrose 36g, DL-methionine 3.2g, L-asparagine 7.5g, and Fe (NH)4)2(SO4)2·6H20.16g of O, 20mL of the solution I, 40mL of the solution II, 144mL of the solution III and 8mL of the solution IV are dissolved in distilled water, the volume is adjusted to 1L by using the distilled water, and the pH value is adjusted to 7.4.
The preparation method of any one of the improved MDFA fermentation culture media comprises the following steps: mixing sucrose 36g, L-asparagine 7.5g, and Fe (NH)4)2(SO4)2·6H20.16g of O, 20mL of the solution I, 40mL of the solution II, 144mL of the solution III and 8mL of the solution IV are dissolved in distilled water, the volume is adjusted to 1L by using the distilled water, and the pH value is adjusted to 7.4 to obtain the culture medium.
Experiments prove that the recombinant bacterium provided by the invention is used for producing CPC, so that the addition of methionine in a culture medium is omitted, and the yield of CPC is improved. Compared with the original strain (i.e. the cephalosporium acremonium CGMCC 3.3795), the recombinant strain has stronger CPC synthesis capacity. The recombinant bacterium provided by the invention has important application value in the aspects of improving the yield of CPC, reducing the production cost and the like.
Drawings
FIG. 1 is a schematic diagram of the construction of recombinant plasmid pAg 1-AcsamsoE.
FIG. 2 is the identification of transformants which are pseudotransgenic for the AcsamsOE gene.
FIG. 3 is a graph showing the effect of methionine on the growth of recombinant bacterium AcsamseOE-1.
FIG. 4 shows the fermentation of recombinant AcsamsoE-1 and the determination of CPC production.
FIG. 5 is a transcriptional analysis of CPC biosynthesis-related genes of recombinant bacterium AcsamseOE-1 during fermentation.
Detailed Description
The following examples are given to facilitate a better understanding of the invention, but do not limit the invention. The experimental procedures in the following examples are conventional unless otherwise specified. The test materials used in the following examples were purchased from a conventional biochemical reagent store unless otherwise specified. The quantitative tests in the following examples, all set up three replicates and the results averaged.
Cephalosporium acremonium CGMCC3.3795 is described in the following documents: the functional research of hexokinase coding gene Achka in Neem, Chengyun, Yuxuan, Liu, Cephalosporium acremonium, Jun Xun, 2017, 36 (3): 323-331.
Bacillus subtilis CGMCC 1.1630 is described in the following references: long L, Yang J, An Y, Liu G.Disction of a glutamatere reducing gene in Acremonium chrysogenum leads to reduction of bits growth, centrosporisorium and antibiotic activity of yield. 114-22. hereinafter, Bacillus subtilis CGMCC 1.1630 is simply called Bacillus subtilis.
Agrobacterium tumefaciens AGL-1 is described in the following documents: CH Khang, SY Park, HS Rho, YH Lee, SKang. Filamethonous fungi (Magnaporthe grisea and Fusarium oxysporum). Methods in molecular Biology, 2006, 344: 403-.
The Pfaffl's process is described in the following documents: pan Y, Wang L, He X, Tian Y, Liu G, TanH. SabR enhancement process via adjustment of the transcriptional level of sang, a path-specific regulatory gene in Streptomyces and microorganisms. BMC Microbiol.2011Jul 20; 11:164.
The vector pEASY-Blunt is a product of Beijing Quanyu gold Biotechnology Co., Ltd, and the product catalog number is CB 101. PrimeScriptTMThe RT kit and 2 XSSYBR Premix Ex Taq are both products of TaKaRa. The thermocycler Mastercycler is a product of the company Eppendorf. The penicillinase is a product of Taixi love (Shanghai) chemical industry development limited company, and the product catalog number is P0310-25 ML. CPC-Zn is a product of Sigma company and has a product catalog number of C3270.
The nucleotide sequence of the plasmid pAg1-G418-P-T (circular) is shown as the sequence 3 in the sequence table.
In the following examples, the plates and media involved are as follows:
TSA resistant plates: mixing tryptone 17g, soytone 3g, glucose 2.5g, sodium chloride 5g, and K2HPO3·3H2Dissolving O2.5g and 15g of agar powder in 1L of distilled water, and adjusting the pH value to 7.0; sterilizing at 115 deg.C under high pressure for 20 min; cooling to 60 deg.C, adding G418 and ThieladinSodium, so that the concentration of G418 and the concentration of the thienamycin sodium in the system are both 200 mug/mL; finally pouring the mixture into a culture dish, and naturally cooling.
LPE plate: dissolving 10g of calcium chloride, 1g of glucose, 1.5g of sodium chloride, 2g of yeast extract and 25g of agar powder in 1L of distilled water, and adjusting the pH value to 6.8; autoclaving at 115 deg.C for 20min, pouring into culture dish, and naturally cooling.
TSA plates without methionine: mixing tryptone 17g, soytone 3g, glucose 2.5g, sodium chloride 5g, and K2HPO3·3H2Dissolving O2.5g and agar powder 15g in 1L distilled water, and adjusting pH to 7.0; sterilizing at 115 deg.C under high pressure for 20 min; then pouring into a culture dish, and naturally cooling.
Methionine-containing TSA plates: mixing tryptone 17g, soytone 3g, glucose 2.5g, sodium chloride 5g, and K2HPO3·3H2Dissolving O2.5g, DL-methionine 3.2g and agar powder 15g in 1L distilled water, and adjusting pH to 7.0; sterilizing at 115 deg.C under high pressure for 20 min; then pouring into a culture dish, and naturally cooling.
LB resistant plates: dissolving 10g of tryptone, 5g of yeast extract, 10g of sodium chloride and 15g of agar powder in 1L of distilled water, and adjusting the pH value to 7.0; sterilizing at 121 deg.C under high pressure for 15 min; cooling to 60 ℃, and adding kanamycin to ensure that the concentration of kanamycin in the system is 75 mug/mL; finally pouring the mixture into a culture dish, and naturally cooling.
Original MDFA fermentation medium: mixing sucrose 36g, DL-methionine 3.2g, L-asparagine 7.5g, and Fe (NH)4)2(SO4)2·6H20.16g of O, 20mL of the solution I, 40mL of the solution II, 144mL of the solution III and 8mL of the solution IV are dissolved in distilled water, the volume is adjusted to 1L by using the distilled water, and the pH value is adjusted to 7.4 to obtain the culture medium.
Modified MDFA fermentation medium: mixing sucrose 36g, L-asparagine 7.5g, and Fe (NH)4)2(SO4)2·6H2O0.16g, solution I20 mL, solution II 40mL, solution III 144mL and solution IV 8mL were dissolved in distilled water and made up to 1L with distilled water, and the pH was adjusted to 7.4 to obtain a medium. Modified MDFA fermentation Medium and Only the original MDFA fermentation MediumOne difference is that it does not contain DL-form methionine.
Solution I was an aqueous solution containing 50% (50mg/100mL) glucose.
The solution II is an aqueous solution containing 50% (v/v) glycerol.
Solution III is prepared by mixing K2HPO4·3H2O 128.61g、KH2PO4·H2O 102g、NaSO4·10H2O 11.5g、MgSO4·7H2O 2.4g、ZnSO4·7H2O 0.2g、MnSO4·4H2O 0.2g、CuSO4·5H2O0.05 g and CaCl2·2H20.5g of O was dissolved in 1L of distilled water.
The solution IV contains 2% (2mg/100mL) Fe (NH)4)2(SO4)2·6H2An aqueous solution of O.
LB liquid medium: dissolving 10g of tryptone, 5g of yeast extract and 10g of sodium chloride in 1L of distilled water, and adjusting the pH value to 7.0; then autoclaved at 121 ℃ for 15 min.
The formulations of MM medium, IM medium and CM plates are shown in Table 1.
TABLE 1
Figure BDA0001362238900000051
Figure BDA0001362238900000061
Note: 20% (20mg/100mL) glucose aqueous solution, 0.01% (0.01mg/100mL) FeSO4The aqueous solution, 1MMES (pH5.3) and kanamycin sulfate aqueous solution (0.2M) were each subjected to filter sterilization and stored at-20 ℃ for use. "-" means absent.
Example 1 obtaining of recombinant bacteria
Firstly, construction of recombinant plasmid pAg1-AcsamsoE
A schematic diagram of the construction of recombinant plasmid pAg1-AcsamsoE is shown in FIG. 1. The method comprises the following specific steps:
1. extracting total RNA of cephalospora acremonium CGMCC3.3795 by using Trizol reagent, and then carrying out reverse transcription to obtain cDNA.
2. Taking the cDNA obtained in the step 1 as a template, adopting a primer SAMSOE-F: 5' -ttaattaaATGTCTGCCAACGGCATCAAGGGCGT-3' (recognition site for restriction enzyme PacI underlined) and primer SAMSOE-R: 5' -ggcgcgc cTTAGAACTTGAGAGGCTTGGGCTGCTCC-3' (recognition sites for the restriction enzyme AscI are underlined) was subjected to PCR amplification to obtain a PCR amplification product of about 1201 bp.
3. And (3) connecting the PCR amplification product obtained in the step (2) with a vector pEASY-Blunt to obtain a recombinant plasmid pEASY-samsOE.
4. The recombinant plasmid pEASY-samsOE is double-digested by restriction enzymes PacI and AscI, and a DNA fragment samsOE of about 1201bp is recovered.
5. The plasmid pAg1-G418-P-T was double-digested with the restriction enzymes PacI and AscI, recovering a vector backbone of about 8600 bp.
6. And connecting the DNA fragment samsOE with a vector skeleton to obtain a recombinant plasmid pAg 1-AcsamsOE.
The recombinant plasmid pAg 1-AcsamseOE was sequenced. According to the sequencing result, the structure of the recombinant plasmid pAg1-AcsamsoE is described as follows: the small fragment between the restriction enzymes PacI and AscI of plasmid pAg1-G418-P-T was substituted into the DNA molecule shown in sequence 1 of the sequence listing. The recombinant plasmid pAg1-Acsamso expresses adenosylmethionine synthetase shown in sequence 2 in the sequence table.
The recombinant plasmid pAg1-AcsamsoE has an expression cassette A, the nucleotide sequence of the expression cassette A is shown as a sequence 4 in a sequence table, wherein the 1 st to 2093 th sites of the sequence 4 in the sequence table from the 5' end are promoters, the 2109 th to 3293 th sites are coding genes for coding adenosylmethionine synthetase, and the 3319 th to 3838 th sites are terminators.
II, obtaining recombinant agrobacterium
The recombinant plasmid pAg 1-AcsamsoOE is introduced into Agrobacterium tumefaciens AGL-1 to obtain recombinant Agrobacterium tumefaciens, which is named AGL-1/pAg 1-AcsamsoOE.
Thirdly, obtaining of transformant of quasi-AcsamsOE gene
1. Single colonies of AGL-1/pAg1-AcsamsoE were inoculated into 5mL of MM medium and cultured at 28 ℃ for 2 days at 200rpm to give culture broth 1.
2. After the step 1 is finished, taking the culture solution 1, and diluting the culture solution to OD by using an IM (instant messenger) culture medium600nmThe OD was 0.15, and then cultured at 28 ℃ for 6 hours at 200rpm to obtain OD600nmAbout 0.6 of inoculum 2.
3. Mixing 100 μ L of culture solution 2 and 100 μ L of spore suspension of Cephalosporium acremonium CGMCC3.3795 (spore concentration in the spore suspension is 1.0 × 10)7pieces/mL) were mixed and then spread evenly on CM plates (glassine paper already spread) and co-cultured for 3d at 25 ℃ upright.
4. After completion of step 3, the co-cultured cells on cellophane were transferred to a TSA-resistant plate and subjected to inverted culture at 28 ℃ for 5-7 days. The transformant capable of growing normally on the TSA-resistant plate is a transformant which is intended to transfer the AcsamsoE gene.
Identification of transformants which were transformed with the AcsamsoOE Gene
1. PCR amplification identification
Genomic DNA of a transformant that is pseudotransferred to the AcsamsOE gene was extracted and used as a template, and the DNA sequence of a transformant prepared from Neo-F: 5' -AGATCTTTAACGCTTACAATTTCC-3' and Neo-R: 5' -AGATCTGAATAGGAACTTCGGAAT-3' and then electrophoresed.
The genomic DNA of the transformant which was transformed with the AcsamsOE gene was replaced with water in the same manner as described above, and the other steps were carried out as a negative control.
According to the method, the genomic DNA of a transformant which is to be transferred with the Acsamsom OE gene is replaced by the genomic DNA of the Cephalosporium acremonium CGMCC3.3795, and other steps are the same and used as a control.
The experimental results are shown in A in FIG. 2 (M is DNA Marker, WT is Cephalosporium acremonium CGMCC3.3795, AcsamsoE is a transformant for transforming the AcsamsoOE gene, and NC is negative control). The result shows that the genome DNA of a transformant which is subjected to AcsamsoOE gene transfer is used as a template, and the primer pair is adopted to amplify to obtain a band of about 2 kb; the primer pair can not amplify to obtain a band of about 2kb by taking water or genome DNA of the cephalosporium acremonium CGMCC3.3795 as a template.
2. qRT-PCR identification
(1) Trizol reagent is adopted to respectively extract the transformant of the AcsamsoOE gene to be transferred and the total RNA of the Cephalosporium acremonium CGMCC3.3795, and then PrimeScriptTM RT kit is adopted to synthesize cDNA.
(2) After the step (1) is completed, performing qRT-PCR (β -actin gene as internal reference) on the AcsamsOE gene in each cDNA by using a thermal cycler Mastercycler, and then calculating the relative expression amount of the AcsamsOE gene by using a Pfaffl's method.
Reaction system: 12.5. mu.L of 2 XSSYBR Premix Ex Taq, 1. mu.L of the forward primer (10. mu. mol. L concentration)-1) 1. mu.L of the downstream primer (10. mu. mol. L in concentration)-1) 0.5. mu.L cDNA template and 10. mu.L ddH2O。
Reaction procedure: 10min at 95 ℃; 95 ℃ for 5s, 58 ℃ for 30s, 72 ℃ for 15s, 40 cycles.
The primers for detecting the AcsamsOE gene are RTACsams-F: 5'-CTATGCCACCGACGAGACTC-3' and RTACsams-R: 5'-TGGGCGGAGATGACAACA-3', and the primers for detecting the β -actin gene are RTactin-F: 5'-AGTCCAAGCGTGGTATCC-3' and RTactin-R: 5'-TAGAAGGCAGGGGCGTTG-3'.
The experimental results are shown in B in FIG. 2 (WT is Cephalosporium acremonium CGMCC3.3795, and AcsamsoE is a transformant for transforming the AcsamsoOE gene). The result shows that the relative expression quantity of the Acsams gene in a transformant of the AcsamsoE gene is obviously increased compared with the initial strain of Acremonium acremonium CGMCC 3.3795.
Therefore, the transformant which is subjected to AcsamsoOE gene transformation and obtained in the third step is a positive transformant which is subjected to AcsamsoOE gene transformation. Three positive transformants which are transformed with the AcsamseOE gene are randomly selected and are sequentially named as a recombinant bacterium AcsamseOE-1, a recombinant bacterium AcsamseOE-2 and a recombinant bacterium AcsamseOE-3.
According to the method of the second to fourth steps, the recombinant plasmid pAg 1-AcsamseOE is replaced by the plasmid pAg1-G418-P-T, the other steps are the same, a transformant of the empty transfer vector is obtained, and the transformant is named as a recombinant bacterium pAg 1-G418-P-T.
Example 2 Effect of methionine on the growth of recombinant bacteria
The bacteria to be detected are recombinant bacteria AcsamseOE-1, recombinant bacteria AcsamseOE-2, recombinant bacteria AcsamseOE-3, recombinant bacteria pAg1-G418-P-T or Cephalosporium acremonium CGMCC 3.3795.
1. Spreading the bacterial liquid of the bacteria to be detected on an LPE plate, culturing at 28 deg.C for 7d, and adding sterile water to obtain a solution with a concentration of 3 × 107And (4) one/mL of bacterial spore suspension to be detected.
2. mu.L of the spore suspension of the bacterium to be tested was spotted on a TSA plate containing no methionine or a TSA plate containing methionine, cultured at 28 ℃ for 7d, and then the growth of the colonies was observed.
The results of some experiments are shown in FIG. 3(WT is Cephalosporium acremonium CGMCC3.3795, and Acsamso is recombinant bacterium Acsamsoe OE-1, and methionine is not added, namely on a TSA plate without methionine, and methionine is added, namely on a TSA plate with methionine). The result shows that the recombinant bacterium AcsamseOE-1, the recombinant bacterium AcsamseOE-2, the recombinant bacterium AcsamseOE-3, the recombinant bacterium pAg1-G418-P-T and the Cephalosporium acremonium CGMCC3.3795 can normally grow under the conditions of no methionine addition and methionine addition, and the growth speeds are basically consistent. As can be seen, the overexpression of the Acsams gene in the Cephalosporium acremonium CGMCC3.3795 does not affect the growth of thalli.
Example 3 fermentation of recombinant bacterium AcsamsoE-1 and measurement of CPC production
The size of the triangular flask in this example was 250 mL.
The bacteria to be detected are recombinant bacteria AcsamseOE-1, recombinant bacteria pAg1-G418-P-T or Cephalosporium acremonium CGMCC 3.3795.
The culture medium to be tested is an original MDFA fermentation culture medium or an improved MDFA fermentation culture medium.
1. And (3) coating the bacterial liquid of the bacteria to be detected on an LPE flat plate, culturing for 7d at 28 ℃, and then adding sterile water to obtain the bacterial spore suspension to be detected.
2. Suspending the spore suspension (containing 3X 10) of the bacteria to be detected7Spores) into a triangular flask containing 40mL of original MDFA fermentation medium, and culturing at 28 ℃ and 220rpm for 48h to obtain seed liquid.
3. Taking 4mL of seed solution, inoculating into a triangular flask containing 40mL of culture medium to be detected (namely, the inoculation amount is 10% (v/v), culturing at 28 ℃ and 220rpm for 5d or 6d to obtain fermentation liquor.
4. Taking the fermentation liquor, centrifuging at 4 ℃ and 5000rpm for 10min, and collecting the supernatant and the precipitate.
And (4) drying and weighing the precipitate collected in the step (4) to obtain the biomass of the thalli.
And (4) taking the supernatant collected in the step (4), and carrying out biological activity detection, namely detecting the CPC yield. The experiment was repeated three times, each repetition of the steps as follows:
(1) inoculating the single clone of the bacillus subtilis to 3mL LB liquid culture medium, culturing at 37 ℃ and 220rpm for 2-3h to obtain a bacterial liquid 1. Then diluting the bacterial liquid 1 to OD by using LB liquid culture medium600nmBacterial liquid 2 was obtained at 0.2.
(2) After the step (1) is finished, 10g of tryptone, 5g of yeast extract, 10g of sodium chloride and 15g of agar powder are dissolved in 1L of distilled water, and the pH value is adjusted to be 7.0; sterilizing at 121 deg.C under high pressure for 15min, cooling to 50 deg.C, collecting 200mL culture medium, adding 1mL bacterial liquid 2 (volume ratio of 1:200) and 1mL penicillinase (volume ratio of 1:200), and mixing; and finally, pouring the mixture into a culture dish, and naturally cooling to obtain the detection flat plate.
(3) After completion of step (2), a punch (6 mm in diameter) was used to punch the wells, 40. mu.L of CPC-Zn aqueous solution (25. mu.g/mL, 50. mu.g/mL, 75. mu.g/mL, 100. mu.g/mL, 125. mu.g/mL or 150. mu.g/mL) was added to the wells, and the zone diameter was measured after culturing in an inverted state at 37 ℃ for 8 hours. And (4) obtaining a standard curve equation for measuring the CPC-Zn titer by taking the concentration of the CPC-Zn as the ordinate and the diameter of the inhibition zone as the abscissa.
The standard curve equation for CPC-Zn titer determination is as follows: y 0.7094x + 0.849; wherein y is log [ CPC-Zn, μ g/mL ], and x is zone diameter-pore diameter (cm).
(4) After completion of step (2), a punch (diameter: 6mm) was used to punch the wells, 40. mu.L of the supernatant collected in step 4 was added to the wells, and after culturing in an inverted state at 37 ℃ for 8 hours, the diameter of the zone of inhibition was measured. And (4) calculating the CPC yield (mu g/mL) of the bacteria to be detected in the culture medium to be detected according to the standard curve equation of the step (3).
The results of some experiments are shown in Table 2 (CPC yield of Cephalosporium acremonium CGMCC3.3795 is highest on 5 days of fermentation, and CPC yield of recombinant bacterium AcsamsoE-1 is highest on 6 days of fermentation, therefore, data of Cephalosporium acremonium CGMCC3.3795 in Table 2 is data on 5 days of fermentation, and data of recombinant bacterium AcsamsoE-1 is data on 6 days of fermentation) and FIG. 4(WT is Cephalosporium acremonium CGMCC3.3795, and AcsamsoE is recombinant bacterium AcsamsoE-1). The result shows that when the strain is cultured in the original MDFA fermentation culture medium (namely the culture medium contains methionine), the biomass of the cephalosporium acremonium CGMCC3.3795, the recombinant bacterium pAg1-G418-P-T and the recombinant bacterium AcsamsoE-1 has no significant difference; compared with the Cephalosporium acremonium CGMCC3.3795, the CPC yield of the recombinant strain AcsamseOE-1 is remarkably improved (about 1.9 times), and the CPC yield of the recombinant strain pAg1-G418-P-T has no remarkable difference. When the strain is cultured in an improved MDFA fermentation culture medium (namely the culture medium does not contain methionine), the biomass of the cephalosporium acremonium CGMCC3.3795, the recombinant bacterium pAg1-G418-P-T and the recombinant bacterium AcsamsoE-1 has no significant difference; compared with the Cephalosporium acremonium CGMCC3.3795, the CPC yield of the recombinant strain AcsamsoOE-1 is remarkably improved (about 3.6 times), and the CPC yield of the recombinant strain pAg1-G418-P-T has no remarkable difference.
The results show that the recombinant bacterium AcsamseOE-1 is used for producing CPC, so that the addition of methionine is omitted, and the yield of CPC is improved. The recombinant bacterium AcsamseOE-1 has important application value in the aspects of improving the yield of CPC, reducing the production cost and the like.
TABLE 2 Biomass and CPC yield of Acremonium acremonium CGMCC3.3795 fermented for 5 days and recombinant bacterium AcsamsoE-1 fermented for 6 days
Figure BDA0001362238900000101
Example 4 transcriptional analysis of CPC biosynthesis-related Gene of recombinant bacterium AcsamsoE-1 in fermentation Process
Both the pcbAB gene and cefEF gene have been shown to be involved in CPC biosynthesis (described in Pengjie Hu, Ying Wang, Jun Zhou, Yuanyuan Pan, Gang Liu. AcstuA, which codes and APSES transcription regulator, is involved in the infection, cephalosporism biosynthesis and cell wall integration of Acremonium chrysogenum. fungalgogenics and Biology 83(2015) 26-40.). Therefore, the level of CPC synthesizing ability of the cells can be evaluated by measuring the transcription levels of the pcbAB gene and cefEF gene of the cells during fermentation.
The size of the triangular flask in this example was 250 mL.
The bacteria to be detected are recombinant bacteria AcsamseOE-1 or Cephalosporium acremonium CGMCC 3.3795.
1. And (3) coating the bacterial liquid of the bacteria to be detected on an LPE flat plate, culturing for 7d at 28 ℃, and then adding sterile water to obtain the bacterial spore suspension to be detected.
2. After completing step 1, the bacterial spore suspension (containing 3X 10) to be tested is added7Spores) into a triangular flask containing 40mL of original MDFA fermentation medium, and culturing at 28 ℃ and 220rpm for 48h to obtain seed liquid.
3. After completing step 2, 4mL of seed solution was inoculated into a flask containing 40mL of modified MDFA fermentation medium (i.e., inoculum size is 10% (v/v), and cultured at 28 ℃ and 220rpm for 2d, 3d, 4d, 5d or 6d to obtain a fermentation broth.
4. And (3) after the step 3 is finished, taking the fermentation liquor, centrifuging for 10min at 4 ℃ and 5000rpm, and collecting precipitates, namely the thalli.
5. After completion of step 4, total RNA of the cells was extracted using Trizol reagent, and then cDNA was synthesized using PrimeScriptTM RT kit.
6. After the step 5 is completed, qRT-PCR (β -actin gene as reference) is carried out on the target gene (pcbAB gene or cefEF gene) in each cDNA by using a thermal cycler Mastercycler, and then the relative expression amount of the target gene is calculated by using a Pfaffl's method.
Reaction system: 12.5. mu.L of 2 XSSYBR Premix Ex Taq, 1. mu.L of the forward primer (10. mu. mol. L concentration)-1) 1. mu.L of the downstream primer (10. mu. mol. L in concentration)-1) 0.5. mu.L cDNA template and 10. mu.L ddH2O。
Reaction procedure: 10min at 95 ℃; 95 ℃ for 5s, 58 ℃ for 30s, 72 ℃ for 15s, 40 cycles.
The primers for detecting the pcbAB gene are RTpcbAB-F: 5'-ACCAGTCCGACGTGCAGAAT-3' and RTpcbAB-R: 5'-TCGGTGATATGGGCCATGTAG-3' are provided.
The primer for detecting the cefEF gene is RTcefEF-F: 5'-CCGTAACCACCAAGGGTATCT-3' and RTCefEF-R: 5'-CTCCTCGCTTCCGTTCTTGA-3' are provided.
The primers for detecting β -actin gene are RTactin-F: 5'-AGTCCAAGCGTGGTATCC-3' and RTactin-R: 5'-TAGAAGGCAGGGGCGTTG-3'.
The experimental results are shown in figure 5 (WT-is Acremonium cephamatum CGMCC3.3795, and AcsamseOE-is recombinant bacterium AcsamseOE-1). Results show that the relative expression quantity of the pcbAB gene in the recombinant strain AcsamsoE-1 is remarkably higher than that of an original strain (namely, Cephalosporium acremonium CGMCC 3.3795) in fermentation from 2d to 6 d; the relative expression quantity of the cefEF gene in the recombinant strain AcsamsoE-1 is obviously higher than that of the original strain (namely, Cephalosporium acremonium CGMCC 3.3795) in the fermentation steps from 2d to 5d
The result shows that the recombinant strain AcsamseOE-1 has stronger CPC synthesis capacity than the original strain (i.e. Cephalosporium acremonium CGMCC 3.3795).
<110> institute of microbiology of Chinese academy of sciences
<120> recombinant bacterium for producing cephalosporin C and application thereof
<160>4
<170>PatentIn version 3.5
<210>1
<211>1185
<212>DNA
<213> Acremonium chrysogenum.
<400>1
atgtctgcca acggcatcaa gggcgtgcag aagcacgagg gtagcttcct cttcacctcc 60
gagtccgtcg gcgagggcca cccggacaag atcgccgatc aggtctccga cgcaatcctc 120
gatgcatgcc tgaaggagga ccccctctcc aaggtggctt gcgagaccgc taccaagacg 180
ggcatgatca tggtcttcgg cgagatcacc acccgcgcca acctcgacta ccagaaggtg 240
gtccgtgact gcatcaagga cattgggtat gacgactcct ccaaggggtt cgattacaag 300
acctgcaacc tgctcgtcgc cattgagcag cagtcccccg atattgctca gggtctccac 360
tacgacaagg ccatcgagga gctcggtgcc ggtgaccagg gcatcatgtt cggctatgcc 420
accgacgaga ctcccgagct cttccctctc agccttctcc tcgcccacaa gctgaacgct 480
gccatgtcca aggctcgccg tgacggcacc ctgccctggc tgcgacccga caccaagacc 540
caggtcaccg tcgagtacac cgaggacaac ggcgctgtca tcccccagcg cgtccacact 600
gttgtcatct ccgcccagca ctccgaggac atcaccaccg agaagctccg tgaggagatc 660
aaggagaaga tcatcaaggc taccatcccc gccaagtacc tcgacgacga cgttgtctac 720
cacattcaac cctccggcaa gttcatcatc ggcggccctc agggtgacgc cggtctgacc 780
ggccgtaaga tcatcgtcga cacctacggt ggctggggtg cccacggtgg tggtgccttc 840
tccggcaagg acttctccaa ggtcgatcgc tcggccgcct acactgcccg ctgggtcgcc 900
aagtcgctgg ttgccgccgg cctcgcccgc cgtgccctcg tccagttctc gtacgccatt 960
ggtgttgccg agcccctctc catccacgtc gacacctacg gcacctccaa gaagacctct 1020
gccgagctcg ttgagatcat cgacaagaac ttcaacctcc gtcccggcgt cattgtccgt 1080
gccctcaacc tcgaccagcc catctacctc cagactgcca agaacggcca ctttggcacc 1140
aaccaggact tcagctggga gcagcccaag cctctcaagt tctaa 1185
<210>2
<211>394
<212>PRT
<213> Acremonium chrysogenum.
<400>2
Met Ser Ala Asn Gly Ile Lys Gly Val Gln Lys His Glu Gly Ser Phe
1 5 10 15
Leu Phe Thr Ser Glu Ser Val Gly Glu Gly His Pro Asp Lys Ile Ala
20 25 30
Asp Gln Val Ser Asp Ala Ile Leu Asp Ala Cys Leu Lys Glu Asp Pro
35 40 45
Leu Ser Lys Val Ala Cys Glu Thr Ala Thr Lys Thr Gly Met Ile Met
50 55 60
Val Phe Gly Glu Ile Thr Thr Arg Ala Asn Leu Asp Tyr Gln Lys Val
65 70 75 80
Val Arg Asp Cys Ile Lys Asp Ile Gly Tyr Asp Asp Ser Ser Lys Gly
85 90 95
Phe Asp Tyr Lys Thr Cys Asn Leu Leu Val Ala Ile Glu Gln Gln Ser
100 105 110
Pro Asp Ile Ala Gln Gly Leu His Tyr Asp Lys Ala Ile Glu Glu Leu
115 120 125
Gly Ala Gly Asp Gln Gly Ile Met Phe Gly Tyr Ala Thr Asp Glu Thr
130 135 140
Pro Glu Leu Phe Pro Leu Ser Leu Leu Leu Ala His Lys Leu Asn Ala
145 150 155 160
Ala Met Ser Lys Ala Arg Arg Asp Gly Thr Leu Pro Trp Leu Arg Pro
165 170 175
Asp Thr Lys Thr Gln Val Thr Val Glu Tyr Thr Glu Asp Asn Gly Ala
180 185 190
Val Ile Pro Gln Arg Val His Thr Val Val Ile Ser Ala Gln His Ser
195 200 205
Glu Asp Ile Thr Thr Glu Lys Leu Arg Glu Glu Ile Lys Glu Lys Ile
210 215 220
Ile Lys Ala Thr Ile Pro Ala Lys Tyr Leu Asp Asp Asp Val Val Tyr
225 230 235 240
His Ile Gln Pro Ser Gly Lys Phe Ile Ile Gly Gly Pro Gln Gly Asp
245 250 255
Ala Gly Leu Thr Gly Arg Lys Ile Ile Val Asp Thr Tyr Gly Gly Trp
260 265 270
Gly Ala His Gly Gly Gly Ala Phe Ser Gly Lys Asp Phe Ser Lys Val
275 280 285
Asp Arg Ser Ala Ala Tyr Thr Ala Arg Trp Val Ala Lys Ser Leu Val
290 295 300
Ala Ala Gly Leu Ala Arg Arg Ala Leu Val Gln Phe Ser Tyr Ala Ile
305 310 315 320
Gly Val Ala Glu Pro Leu Ser Ile His Val Asp Thr Tyr Gly Thr Ser
325 330 335
Lys Lys Thr Ser Ala Glu Leu Val Glu Ile Ile Asp Lys Asn Phe Asn
340 345 350
Leu Arg Pro Gly Val Ile Val Arg Ala Leu Asn Leu Asp Gln Pro Ile
355 360 365
Tyr Leu Gln Thr Ala Lys Asn Gly His Phe Gly Thr Asn Gln Asp Phe
370 375 380
Ser Trp Glu Gln Pro Lys Pro Leu Lys Phe
385 390
<210>3
<211>8626
<212>DNA
<213> Artificial sequence
<220>
<223>
<400>3
caaattgacg cttagacaac ttaataacac attgcggacg tttttaatgt actggggtgg 60
tttttctttt caccagtgag acgggcaaca gcggcgccat tcgccattca ggctgcgcaa 120
ctgttgggaa gggcgatcgg tgcgggcctc ttcgctatta cgccagctgg cgaaaggggg 180
atgtgctgca aggcgattaa gttgggtaac gccagggttt tcccagtcac gacgttgtaa 240
aacgacggcc agtgaattcg agctcggtac caaggcccgg gctggccacg gccgcctagg 300
cgcgcaagga tcctctagaa taggaacttc ggaataggaa cttcaaagcg tttccgaaaa 360
cgagcgcttc cgaaaatgca acgcgagctg cgcacataca gctcactgtt cacgtcgcac 420
ctatatctgc gtgttgcctg tatatatata tacatgagaa gaacggcata gtgcgtgttt 480
atgcttaaat gcgtacttat atgcgtctat ttatgtagga tgaaaggtag tctagtacct 540
cctgtgatat tatcccattc catgcggggt atcgtatgct tccttcagca ctacccttta 600
gctgttctat atgctgccac tcctcaattg gattagtctc atccttcaat gctatcattt 660
cctttgatat tggatcatat gcatagtacc gaaaactagg ccagcagtag acacttggaa 720
tctaaacaga cattatcatc atcatgcaac atgcatgtac tgtctgatgt attaagagta 780
taggggtcaa caactagagt gtctgacagg tatatctagc agtttgattt gaccattctt 840
ttattaaaac actgtaaccc gcaacgaaga actcctccgc ttcaagtcaa gaatgcgcat 900
atgtgcgtaa aatcgacaag cccggcggca ttccaccgag cagggtattg cctttggcac 960
tttacgtgcg cagaggagcc tgaatgttga gtggaatgat tcagaagaac tcgtcaagaa 1020
ggcgatagaa ggcgatgcgc tgcgaatcgg gagcggcgat accgtaaagc acgaggaagc 1080
ggtcagccca ttcgccgcca agctcttcag caatatcacg ggtagccaac gctatgtcct 1140
gatagcggtc cgccacaccc agccggccac agtcgatgaa tccagaaaag cggccatttt 1200
ccaccatgat attcggcaag caggcatcgc catgggtcac gacgagatcc tcgccgtcgg 1260
gcatgctcgc cttgagcctg gcgaacagtt cggctggcgc gagcccctga tgctcttcgt 1320
ccagatcatc ctgatcgaca agaccggctt ccatccgagt acgtgctcgc tcgatgcgat 1380
gtttcgcttg gtggtcgaat gggcaggtag ccggatcaag cgtatgcagc cgccgcattg 1440
catcagccat gatggatact ttctcggcag gagcaaggtg agatgacagg agatcctgcc 1500
ccggcacttc gcccaatagc agccagtccc ttcccgcttc agtgacaacg tcgagcacag 1560
ctgcgcaagg aacgcccgtc gtggccagcc acgatagccg cgctgcctcg tcttgcagtt 1620
cattcagggc accggacagg tcggtcttga caaaaagaac cgggcgcccc tgcgctgaca 1680
gccggaacac ggcggcatca gagcagccga ttgtctgttg tgcccagtca tagccgaata 1740
gcctctccac ccaagcggcc ggagaacctg cgtgcaatcc atcttgttca atcattttga 1800
agattgggtt cctgcgaagc tgtatcaata agttggatat ggaatgaatt ggagattgcc 1860
gtgcggaacg tgcagtggtg gtgtgggatg atgcgtgttg ttgggaagag tcgggactcg 1920
cgacagtgat ggggttacgg ttcgatgggg ttgagttggt gacggatcga gtggtgtcaa 1980
ctgtgttgct ggctggcagg ctgggaacga ggtgtttcca ggttggtgct tgactggcac 2040
tgctggggcg ctggggcgag catcatattc ctgccgccaa tcaggtagcg cttgcgaagg 2100
cggctggaaa ttgggggttt cggaatgtcg tcaagcggga accaatttga gtacccaatt 2160
cgccctatag tgagtcgtat tacgcgcgct cactggccgt cgttttacaa cgtcgtgact 2220
gggaaaaccc tggcgttacc caacttaatc gccttgcagc acatccccct ttcgccagct 2280
ggcgtaatag cgaagaggcc cgcaccgatc gcccttccca acagttgcgc agcctgaatg 2340
gcgaatggaa attgtaagcg ttaagatcta gaggatcccc cgactagttg gtaaaaacga 2400
gcaagcgagc tctagtgttg caaatacgag accataatac ctacctcggc catacaaata 2460
cgctggtgca cctctcaaca tcgaaacaca acaacccgac tcgcctgatc aagctggcta 2520
ttagacagcc aagcgattcc gtcacgtctt cccattgaac gagtctagaa cggaaagcaa 2580
aaaaagttat tgtatatcaa cctcagcttc ctacacccct aggctcgcat ccctaaacgc 2640
atccgactac aaaagtggcc gccgtcatgt ctgttccgag aaaaggcaac gcccaccacc 2700
gcctgaccat gtgaaataac ttttcgtaaa tatgagactt gagtgggata cgcgcgcagc 2760
tgagtagacg ttgcatcggt cgccaccgac tccgacatct tggcgttctt ttgcggaggg 2820
tggaaggatt tggttctggc cggttgcctt gtcttttcga acctgtcaac cttacattcg 2880
ggtatccggc ttcccgacga caacatacac tagtgcgcga tcgcggccgg ccggcgcgcc 2940
gtttaaacgg atttaaatta attaatgtcg actttgattg atctgggaag attattagcc 3000
atggccagca aaagtttaac gaagagccga gagccgatga tgcggggagt gcgtgaccgg 3060
agaattcaaa agcagcaata gcagcagaag cagtagaagc aacagctaag tcatctgctg 3120
gccgcccgag ggacgcgacg agaatgggac gaggtgagct gaggttgggt gggaaggttt 3180
tggaggaggg gcgaggggga agctcagagc tttcccccgg agctcgcggg gctgcggaag 3240
agctcaaagg caagacgaac gtgagcaggg cacttcactt actatagtag ttttttgaag 3300
aagagtgagc ttcgtggaat aataatcgac gcttttcgtt aacgacgacg gatgggttct 3360
cgggaggacg tggatggaag aaggaagaat ggagggaggg aggaggggat agaagcgaag 3420
ctgaaagggc tctcttattc acgcgccctt tccgccaggt gcgtaaggta cttggtaggt 3480
aaagtagttg ccaacattcg tctgatcatg gaatcacggt aacacgggct tgattatgaa 3540
cccccactaa aaccaaagtg gaaagaaatg gcgcattatt catacaggtg ttgggcgaaa 3600
atttccgtcc gctcacgaaa cctgctggta cgaaggaaat acatgcattt tccggtgatg 3660
ttccagtaag tgacgcagtt gatcttacct aaccaggtgg tcgctcacaa cggcgccaca 3720
gtgctccagc aacggtaccg catgagccga agggtcgggc tgttgttggc atagagttag 3780
tggaggtgaa tattttctat cagcctgtgc gtccttatac ccgcggctgg gcggagctgc 3840
atgctcgtat aagataattc ttgcttggta tgtacgacga ctcgtaccag gattaatact 3900
actactctgg tagtacctta attacctact agtagtattg aatccggata cagacgggag 3960
taatcgacgg agggtacgga tactctttgc tgttctattc cgtacttgcc cgtcgtcccc 4020
tcatccctca gccgccagct tagaaaccac tctgatctct acacagccgt atcggacgtt 4080
tacttttggg aaattgacat atctacagta cctatcccac cagggcccaa cacgcatgcc 4140
accgattacc atgctatgac ttcaccactt ctgttgacga ttcttctatt cacaaccgtc 4200
gtgatggcca ctttcaaaag gctttcgcct gcaggcatgg ctggatgcga tagtctgcgg 4260
ccgaacgtcc cggtgcagtt atcatcgagg tctgccagcg gcggacggac tgcctgtctg 4320
gcctttcccc tcttctaccc cccctcaccc gcgccgattt cgtgtttttt ccgtcatcgc 4380
cagcaacact gcgagcagca cgctgctgta gccggcattg gccgcacaga ccacggcctc 4440
cgacatccgc actgttgcct gaggcaccag tgttttggcc ttctggtgca ctaagatttt 4500
cgcggccacc gccactcgcg attgggttta gcgccaatgt cgttagaggc aagaggagcg 4560
gcggcggggc gtctctgaga tgagcactcc ctggcgcaca tcgccaactt gtctctggtt 4620
ggccagctgc gtccgggtcc cagtacgtac cgcccatgta ccctgccact gcagcccacc 4680
tgcccgcctt cccagcccag cagcaggctt cgaggtctcc ctggacactt gctgcaactt 4740
acgcgtgcga cgacgactaa ggtgaagggt gtccgcccgc tgctggcgtg cccgtgcaat 4800
gcgctgcgac cggcggcgtc cagcacccat cgcccagcct gccacccagc accaacaatg 4860
ccaccaaacc cacccagccc attcagtgca gcgccagcag gcaagttcag ctctcattct 4920
caggcgctct ttccccatcc atccgctctc ctctcctccc attcctcact ctctcctcgt 4980
gccctccccc aaacctcttc tcttttcacg accggactat tcttacctgg gcgcccgacc 5040
gccgaacctc tgccttctac gctgggtcga cctgcaggca tgcaagcttc gtgactccct 5100
taattctccg ctcatgatca gattgtcgtt tcccgccttc agtttaaact atcagtgttt 5160
gacaggatat attggcgggt aaacctaaga gaaaagagcg tttattagaa taatcggata 5220
tttaaaaggg cgtgaaaagg tttatccgtt cgtccatttg tttgttcatg ccaaccacag 5280
ggttccagat ccgacgagca aggcaagacc gagcgccttt gcgacgctca ccgggctggt 5340
tgccctcgcc gctgggctgg cggccgtcta tggccctgca aacgcgccag aaacgccgtc 5400
gaagccgtgt gcgagacacc gcggccgccg gcgttgtgga tacctcgcgg aaaacttggc 5460
cctcactgac agatgagggg cggacgttga cacttgaggg gccgactcac ccggcgcggc 5520
gttgacagat gaggggcagg ctcgatttcg gccggcgacg tggagctggc cagcctcgca 5580
aatcggcgaa aacgcctgat tttacgcgag tttcccacag atgatgtgga caagcctggg 5640
gataagtgcc ctgcggtatt gacacttgag gggcgcgact actgacagat gaggggcgcg 5700
atccttgaca cttgaggggc agagtgctga cagatgaggg gcgcacctat tgacatttga 5760
ggggctgtcc acaggcagaa aatccagcat ttgcaagggt ttccgcccgt ttttcggcca 5820
ccgctaacct gtcttttaac ctgcttttaa accaatattt ataaaccttg tttttaacca 5880
gggctgcgcc ctgtgcgcgt gaccgcgcac gccgaagggg ggtgcccccc cttctcgaac 5940
cctcccggcc cgctaacgcg ggcctcccat ccccccaggc gtacgccact ggagcacctc 6000
aaaaacacca tcatacacta aatcagtaag ttggcagcat cacccataat tgtggtttca 6060
aaatcggctc cgtcgatact atgttatacg ccaactttga aaacaacttt gaaaaagctg 6120
ttttctggta tttaaggttt tagaatgcaa ggaacagtga attggagttc gtcttgttat 6180
aattagcttc ttggggtatc tttaaatact gtagaaaaga ggaaggaaat aataaatggc 6240
taaaatgaga atatcaccgg aattgaaaaa actgatcgaa aaataccgct gcgtaaaaga 6300
tacggaagga atgtctcctg ctaaggtata taagctggtg ggagaaaatg aaaacctata 6360
tttaaaaatg acggacagcc ggtataaagg gaccacctat gatgtggaac gggaaaagga 6420
catgatgcta tggctggaag gaaagctgcc tgttccaaag gtcctgcact ttgaacggca 6480
tgatggctgg agcaatctgc tcatgagtga ggccgatggc gtcctttgct cggaagagta 6540
tgaagatgaa caaagccctg aaaagattat cgagctgtat gcggagtgca tcaggctctt 6600
tcactccatc gacatatcgg attgtcccta tacgaatagc ttagacagcc gcttagccga 6660
attggattac ttactgaata acgatctggc cgatgtggat tgcgaaaact gggaagaaga 6720
cactccattt aaagatccgc gcgagctgta tgatttttta aagacggaaa agcccgaaga 6780
ggaacttgtc ttttcccacg gcgacctggg agacagcaac atctttgtga aagatggcaa 6840
agtaagtggc tttattgatc ttgggagaag cggcagggcg gacaagtggt atgacattgc 6900
cttctgcgtc cggtcgatca gggaggatat cggggaagaa cagtatgtcg agctattttt 6960
tgacttactg gggatcaagc ctgattggga gaaaataaaa tattatattt tactggatga 7020
attgttttag tacctagatg tggcgcaacg atgccggcga caagcaggag cgcaccgact 7080
tcttccgcat caagtgtttt ggctctcagg ccgaggccca cggcaagtat ttgggcaagg 7140
ggtcgctggt attcgtgcag ggcaagattc ggaataccaa gtacgagaag gacggccaga 7200
cggtctacgg gaccgacttc attgccgata aggtggatta tctggacacc aaggcaccag 7260
gcgggtcaaa tcaggaataa gggcacattg ccccggcgtg agtcggggca atcccgcaag 7320
gagggtgaat gaatcggacg tttgaccgga aggcatacag gcaagaactg atcgacgcgg 7380
ggttttccgc cgaggatgcc gaaaccatcg caagccgcac cgtcatgcgt gcgccccgcg 7440
aaaccttcca gtccgtcggc tcgatggtcc agcaagctac ggccaagatc gagcgcgaca 7500
gcgtgcaact ggctccccct gccctgcccg cgccatcggc cgccgtggag cgttcgcgtc 7560
gtctcgaaca ggaggcggca ggtttggcga agtcgatgac catcgacacg cgaggaacta 7620
tgacgaccaa gaagcgaaaa accgccggcg aggacctggc aaaacaggtc agcgaggcca 7680
agcaggccgc gttgctgaaa cacacgaagc agcagatcaa ggaaatgcag ctttccttgt 7740
tcgatattgc gccgtggccg gacacgatgc gagcgatgcc aaacgacacg gcccgctctg 7800
ccctgttcac cacgcgcaac aagaaaatcc cgcgcgaggc gctgcaaaac aaggtcattt 7860
tccacgtcaa caaggacgtg aagatcacct acaccggcgt cgagctgcgg gccgacgatg 7920
acgaactggt gtggcagcag gtgttggagt acgcgaagcg cacccctatc ggcgagccga 7980
tcaccttcac gttctacgag ctttgccagg acctgggctg gtcgatcaat ggccggtatt 8040
acacgaaggc cgaggaatgc ctgtcgcgcc tacaggcgac ggcgatgggc ttcacgtccg 8100
accgcgttgg gcacctggaa tcggtgtcgc tgctgcaccg cttccgcgtc ctggaccgtg 8160
gcaagaaaac gtcccgttgc caggtcctga tcgacgagga aatcgtcgtg ctgtttgctg 8220
gcgaccacta cacgaaattc atatgggaga agtaccgcaa gctgtcgccg acggcccgac 8280
ggatgttcga ctatttcagc tcgcaccggg agccgtaccc gctcaagctg gaaaccttcc 8340
gcctcatgtg cggatcggat tccacccgcg tgaagaagtg gcgcgagcag gtcggcgaag 8400
cctgcgaaga gttgcgaggc agcggcctgg tggaacacgc ctgggtcaat gatgacctgg 8460
tgcattgcaa acgctagggc cttgtggggt cagttccggc tggatctgct ctcccgctga 8520
cgccgtcccg gactgatggg ctgcctgtat cgagtggtga ttttgtgccg agctgccggt 8580
cggggagctg ttggctggct ggtggcagga tatattgtgg tgtaaa 8626
<210>4
<211>3838
<212>DNA
<213> Artificial sequence
<220>
<223>
<400>4
ggtcgcatct tccgtctcca agccgccagc ccgcgggtcc attcttatca ggccagcact 60
tttctcttct ccaaaccccc tcccgtgctc ctctctcact ccttaccctc ctctcctctc 120
gcctacctac ccctttctcg cggactctta ctctcgactt gaacggacga ccgcgacgtg 180
acttacccga cccacccaaa ccaccgtaac aaccacgacc caccgtccga cccgctaccc 240
acgacctgcg gcggccagcg tcgcgtaacg tgcccgtgcg gtcgtcgccc gcctgtggga 300
agtggaatca gcagcagcgt gcgcattcaa cgtcgttcac aggtccctct ggagcttcgg 360
acgacgaccc gacccttccg cccgtccacc cgacgtcacc gtcccatgta cccgccatgc 420
atgaccctgg gcctgcgtcg accggttggt ctctgttcaa ccgctacacg cggtccctca 480
cgagtagagt ctctgcgggg cggcggcgag gagaacggag attgctgtaa ccgcgatttg 540
ggttagcgct caccgccacc ggcgctttta gaatcacgtg gtcttccggt tttgtgacca 600
cggagtccgt tgtcacgcct acagcctccg gcaccagaca cgccggttac ggccgatgtc 660
gtcgcacgac gagcgtcaca acgaccgcta ctgccttttt tgtgctttag ccgcgcccac 720
tcccccccat cttctcccct ttccggtctg tccgtcaggc aggcggcgac cgtctggagc 780
tactattgac gtggccctgc aagccggcgt ctgatagcgt aggtcggtac ggacgtccgc 840
tttcggaaaa ctttcaccgg tagtgctgcc aacacttatc ttcttagcag ttgtcttcac 900
cacttcagta tcgtaccatt agccaccgta cgcacaaccc gggaccaccc tatccatgac 960
atctatacag ttaaagggtt ttcatttgca ggctatgccg acacatctct agtctcacca 1020
aagattcgac cgccgactcc ctactcccct gctgcccgtt catgccttat cttgtcgttt 1080
ctcataggca tgggaggcag ctaatgaggg cagacatagg cctaagttat gatgatcatc 1140
cattaattcc atgatggtct catcatcata attaggacca tgctcagcag catgtatggt 1200
tcgttcttaa tagaatatgc tcgtacgtcg aggcgggtcg gcgcccatat tcctgcgtgt 1260
ccgactatct tttataagtg gaggtgattg agatacggtt gttgtcgggc tgggaagccg 1320
agtacgccat ggcaacgacc tcgtgacacc gcggcaacac tcgctggtgg accaatccat 1380
tctagttgac gcagtgaatg accttgtagt ggccttttac gtacataaag gaagcatggt 1440
cgtccaaagc actcgcctgc ctttaaaagc gggttgtgga catacttatt acgcggtaaa 1500
gaaaggtgaa accaaaatca cccccaagta ttagttcggg cacaatggca ctaaggtact 1560
agtctgctta caaccgttga tgaaatggat ggttcatgga atgcgtggac cgcctttccc 1620
gcgcacttat tctctcggga aagtcgaagc gaagataggg gaggagggag ggaggtaaga 1680
aggaagaagg taggtgcagg agggctcttg ggtaggcagc agcaattgct tttcgcagct 1740
aataataagg tgcttcgagt gagaagaagt tttttgatga tatcattcac ttcacgggac 1800
gagtgcaagc agaacggaaa ctcgagaagg cgtcggggcg ctcgaggccc cctttcgaga 1860
ctcgaagggg gagcggggag gaggttttgg aagggtgggt tggagtcgag tggagcaggg 1920
taagagcagc gcagggagcc cgccggtcgt ctactgaatc gacaacgaag atgacgaaga 1980
cgacgataac gacgaaaact taagaggcca gtgcgtgagg ggcgtagtag ccgagagccg 2040
agaagcaatt tgaaaacgac cggtaccgat tattagaagg gtctagttag ttttcagctg 2100
taattaatat gtctgccaac ggcatcaagg gcgtgcagaa gcacgagggt agcttcctct 2160
tcacctccga gtccgtcggc gagggccacc cggacaagat cgccgatcag gtctccgacg 2220
caatcctcga tgcatgcctg aaggaggacc ccctctccaa ggtggcttgc gagaccgcta 2280
ccaagacggg catgatcatg gtcttcggcg agatcaccac ccgcgccaac ctcgactacc 2340
agaaggtggt ccgtgactgc atcaaggaca ttgggtatga cgactcctcc aaggggttcg 2400
attacaagac ctgcaacctg ctcgtcgcca ttgagcagca gtcccccgat attgctcagg 2460
gtctccacta cgacaaggcc atcgaggagc tcggtgccgg tgaccagggc atcatgttcg 2520
gctatgccac cgacgagact cccgagctct tccctctcag ccttctcctc gcccacaagc 2580
tgaacgctgc catgtccaag gctcgccgtg acggcaccct gccctggctg cgacccgaca 2640
ccaagaccca ggtcaccgtc gagtacaccg aggacaacgg cgctgtcatc ccccagcgcg 2700
tccacactgt tgtcatctcc gcccagcact ccgaggacat caccaccgag aagctccgtg 2760
aggagatcaa ggagaagatc atcaaggcta ccatccccgc caagtacctc gacgacgacg 2820
ttgtctacca cattcaaccc tccggcaagt tcatcatcgg cggccctcag ggtgacgccg 2880
gtctgaccgg ccgtaagatc atcgtcgaca cctacggtgg ctggggtgcc cacggtggtg 2940
gtgccttctc cggcaaggac ttctccaagg tcgatcgctc ggccgcctac actgcccgct 3000
gggtcgccaa gtcgctggtt gccgccggcc tcgcccgccg tgccctcgtc cagttctcgt 3060
acgccattgg tgttgccgag cccctctcca tccacgtcga cacctacggc acctccaaga 3120
agacctctgc cgagctcgtt gagatcatcg acaagaactt caacctccgt cccggcgtca 3180
ttgtccgtgc cctcaacctc gaccagccca tctacctcca gactgccaag aacggccact 3240
ttggcaccaa ccaggacttc agctgggagc agcccaagcc tctcaagttc taaccggccg 3300
gcgctagcgc gtgatcacca tacaacagca gcccttcggc ctatgggctt acattccaac3360
tgtccaagct tttctgttcc gttggccggt cttggtttag gaaggtggga ggcgttttct 3420
tgcggttcta cagcctcagc caccgctggc tacgttgcag atgagtcgac gcgcgcatag 3480
ggtgagttca gagtataaat gcttttcaat aaagtgtacc agtccgccac cacccgcaac 3540
ggaaaagagc cttgtctgta ctgccgccgg tgaaaacatc agcctacgca aatccctacg 3600
ctcggatccc cacatccttc gactccaact atatgttatt gaaaaaaacg aaaggcaaga 3660
tctgagcaag ttacccttct gcactgcctt agcgaaccga cagattatcg gtcgaactag 3720
tccgctcagc ccaacaacac aaagctacaa ctctccacgt ggtcgcataa acataccggc 3780
tccatccata ataccagagc ataaacgttg tgatctcgag cgaacgagca aaaatggt 3838

Claims (2)

1. The application of the recombinant bacteria or the microbial inoculum containing the recombinant bacteria in the production of cephalosporin C;
the preparation method of the recombinant bacterium comprises the following steps: increasing the content of adenosylmethionine synthetase in the fermentation strain to obtain recombinant strain; the germination strain is cephalosporium acremonium; the amino acid sequence of the adenosylmethionine synthetase is shown as a sequence 2 in a sequence table; the method for improving the content and/or the activity of the adenosylmethionine synthetase in the starting bacteria comprises the steps of introducing nucleic acid molecules for coding the adenosylmethionine synthetase into the starting bacteria; the nucleic acid molecule for coding the adenosylmethionine synthetase is shown as a sequence 1 in a sequence table.
2. A method for producing cephalosporin C, comprising the step of fermentatively culturing the recombinant bacterium of claim 1 to obtain cephalosporin C;
the preparation method of the recombinant bacterium comprises the following steps: increasing the content of adenosylmethionine synthetase in the fermentation strain to obtain recombinant strain; the germination strain is cephalosporium acremonium; the amino acid sequence of the adenosylmethionine synthetase is shown as a sequence 2 in a sequence table; the method for improving the content and/or the activity of the adenosylmethionine synthetase in the starting bacteria comprises the steps of introducing nucleic acid molecules for coding the adenosylmethionine synthetase into the starting bacteria; the nucleic acid molecule for coding the adenosylmethionine synthetase is shown as a sequence 1 in a sequence table.
CN201710623482.XA 2017-07-27 2017-07-27 Recombinant bacterium for producing cephalosporin C and application thereof Active CN107201318B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710623482.XA CN107201318B (en) 2017-07-27 2017-07-27 Recombinant bacterium for producing cephalosporin C and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710623482.XA CN107201318B (en) 2017-07-27 2017-07-27 Recombinant bacterium for producing cephalosporin C and application thereof

Publications (2)

Publication Number Publication Date
CN107201318A CN107201318A (en) 2017-09-26
CN107201318B true CN107201318B (en) 2020-04-21

Family

ID=59911256

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710623482.XA Active CN107201318B (en) 2017-07-27 2017-07-27 Recombinant bacterium for producing cephalosporin C and application thereof

Country Status (1)

Country Link
CN (1) CN107201318B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109971660A (en) * 2017-12-28 2019-07-05 上海医药工业研究院 A kind of preparation method of cephalosporin and its genetic engineering bacterium used
CN113493745B (en) * 2020-03-18 2023-09-15 中国科学院微生物研究所 Genetically engineered bacterium for producing cephalosporin C and construction method thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1357630A (en) * 2001-11-30 2002-07-10 中国科学院上海生物化学研究所 Method of producing adenosylmethionine
CN102719473A (en) * 2012-06-28 2012-10-10 中国科学院微生物研究所 Acremonium-chrysogenum engineering bacterium and construction method thereof
CN103757086A (en) * 2014-01-09 2014-04-30 集美大学 Method for synthesizing S-adenosylmethionine through coupling of escherichia coli and saccharomyces cerevisiae
CN105524849A (en) * 2016-02-01 2016-04-27 中国科学院微生物研究所 Construction and application of cephalosporin high-yield gene engineering strain independent from methionine

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1357630A (en) * 2001-11-30 2002-07-10 中国科学院上海生物化学研究所 Method of producing adenosylmethionine
CN102719473A (en) * 2012-06-28 2012-10-10 中国科学院微生物研究所 Acremonium-chrysogenum engineering bacterium and construction method thereof
CN103757086A (en) * 2014-01-09 2014-04-30 集美大学 Method for synthesizing S-adenosylmethionine through coupling of escherichia coli and saccharomyces cerevisiae
CN105524849A (en) * 2016-02-01 2016-04-27 中国科学院微生物研究所 Construction and application of cephalosporin high-yield gene engineering strain independent from methionine

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
GenBank.S-adenosylmethionine synthase-like protein [Acremonium chrysogenum ATCC 11550],GenBank: KFH48080.1.《GenBank》.2014,第1-2页. *
GenBank:KFH47835.1;GenBank;《GenBank》;20140815;第1页 *
S-adenosylmethionine synthase-like protein [Acremonium chrysogenum ATCC 11550],GenBank: KFH48080.1;GenBank;《GenBank》;20140815;第1页 *
甲硫氨酸在头孢菌素C生物合成中的作用;廖福荣;《国外医药(抗生素分册)》;20001130;第11卷(第6期);第255-265页 *

Also Published As

Publication number Publication date
CN107201318A (en) 2017-09-26

Similar Documents

Publication Publication Date Title
EP1246921A2 (en) Increased lysine production by gene amplification using coryneform bacteria
WO2013132518A1 (en) Recombinant nitrogen fixing microorganism and uses thereof
CN104762247B (en) Improve the engineering strain and construction method of production ascosin yield
CN111621458B (en) BVG90_11450 gene-deleted serratia marcescens engineering bacterium
CN107201318B (en) Recombinant bacterium for producing cephalosporin C and application thereof
EP2597152B1 (en) Genetically engineered strain wsj-ia for producing isovaleryl spiramycin i.
CN113736720B (en) Rhodopseudomonas palustris capable of producing lycopene in high yield, construction method and application thereof
CN116926092B (en) Pantothenate kinase gene RkPank and application thereof
CN112111439A (en) Saccharopolyspora spinosa for high yield of spinosad and method for improving yield of spinosad
CN107988092B (en) Arthrobacter simplex mutant strain with stress tolerance and engineering bacterium
CN114854703B (en) Flavone synthase I/flavanone-3-hydroxylase and application thereof in field of flavonoid compound synthesis
CN112501053B (en) Bacillus amyloliquefaciens HBNS-1, application thereof and agricultural fertilizer prepared from same
CN101892186B (en) Genetic engineering bacterium of streptomyces coeruleorubidus for producing epidaunorubicin and preparation method thereof
CN114507684B (en) Method for inhibiting target gene expression in Mediterranean salt-rich bacteria
KR102263796B1 (en) Process for producing a beta-glucan polymer and genetically modified microorganisms useful in this process
CN111378675A (en) Biosynthesis gene of eremophilane sesquiterpene in catharanthus roseus and application
CN110438144B (en) Method for enhancing expression of exoY gene and improving flocculant yield of flocculant-producing bacteria F2
CN113717914B (en) Efficient homologous recombination amycolatopsis engineered strain, construction method and application thereof
CN113604413B (en) Recombinant strain, preparation method and application
CN116855393A (en) Genetically engineered bacterium for producing FR901379 derivative and application thereof
CN114045300A (en) Construct, vector and cyanobacterium for synthesizing olivinic acid and method for producing olivinic acid in cyanobacterium
CN115029365A (en) Construction and application of antibiotic-free efficient stable expression system of escherichia coli probiotics EcN
CN116676353A (en) Streptomyces coelicolor M145-chry and application thereof in fermentation production of aureomycin
CN117917476A (en) Resistance gene and application thereof
CN118146962A (en) Leptosporium polysaccharide engineering strain for improving butene-based spinosyn yield, and construction method and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant